While this migration continues in more advanced stages, such mobilization relies upon tumor-derived factors to accumulate in the TME where they inhibit T-cell proliferation and activation, often associated with decreased levels of CD8 + T cells48. This evidence concerns the gene CD8A and neoplasm.